Serotonin News and Research

Latest Serotonin News and Research

A psychedelic drug plus psychotherapy could help improve PTSD symptoms

Post-traumatic stress disorder (PTSD) affects millions of people each year, mostly survivors and witnesses of terrifying or shocking events, such as warfare, assaults or disasters. Because existing treatments don't work for everyone, new therapies are urgently needed.

22 Mar 2022

Novel metabolic mechanisms contribute to how ovarian cancer evades immune attack, research finds

High-grade serous carcinoma is the most aggressive form of ovarian cancer and accounts for the majority of advanced-stage cases.

16 Mar 2022

Study delineates how drug-induced changes of conscious awareness are rooted in neurotransmitter receptors

Psychedelics are now a rapidly growing area of neuroscience and clinical research, one that may produce much-needed new therapies for disorders such as depression and schizophrenia.

16 Mar 2022

Researchers unravel how parent's gene impact the behavior of children

Parenting is not the only way moms and dads impact the behavior of their offspring. Genes matter, too. And although most of our genes are inherited in pairs-;one copy from each parent-;moms and dads exert their genetic influence in different ways.

8 Mar 2022

Touch-sensing protein in the gut likely plays a key role in constipation

When we eat food, our gut somehow senses its presence to begin shifting it along our digestive tract, but the question has always been – how?

8 Mar 2022

Pregnant and postpartum women experience depression, anxiety despite treatment with antidepressants

Despite using antidepressants (selective serotonin reuptake inhibitors), many pregnant women had lingering depression and anxiety symptoms throughout their pregnancy and postpartum, reports a new Northwestern Medicine study.

4 Mar 2022

TTUHSC expert wins NIH renewal grant to continue research on neurological disorders

According to the Global Burden of Disease study, neurological disorders are the leading cause of disability and the second leading cause of death after heart disease.

21 Feb 2022

UC joins nationwide trial to evaluate efficacy of repurposed drugs for mild-to-moderate COVID-19

The University of Cincinnati is joining a nationwide study to evaluate repurposed medications in the search for effective, safe treatments for mild-to-moderate COVID-19. Repurposed medications are those already approved by the U.S. Food and Drug Administration for other indications.

16 Feb 2022

$Medications, measurements of physical function could predict fall and fracture risk in older women$

Medications, measurements of physical function could predict fall and fracture risk in older women

In older women, inability to stand on one leg for more than a few seconds is a risk factor for fracture. Another physical test yields similar results. Moreover, SSRIs can be linked to relatively poor physical function, a University of Gothenburg thesis shows.

14 Feb 2022

Drugs used to increase insulin signaling may be effective therapeutic strategy for autism

Drugs to increase insulin signaling may be effective for treating autism say Lancaster University researchers, who have discovered how a genetic change impacts on insulin signaling and glucose metabolism in the brain.

10 Feb 2022

UCLA researchers develop a smartwatch that assesses cortisol levels found in sweat

The human body responds to stress, from the everyday to the extreme, by producing a hormone called cortisol.

9 Feb 2022

Cerebrovascular impairment persists months after severe acute COVID-19, UK study

Researchers in the United Kingdom have conducted an observational cohort study on hospitalized patients and have found that the degree of severity of acute coronavirus disease 2019 (COVID-19) predicts the occurrence of chronic cerebrovascular impairment. The study further suggests that the levels of cerebrovascular impairment are associated with worse cognitive, mental, and physical well-being.

7 Feb 2022

Scientists identify genome regions linked to migraine risk

An international consortium of leading migraine scientists identified more than 120 regions of the genome that are connected to risk of migraine.

3 Feb 2022

Psychedelic analogs show antidepressant-like activity in mice without causing hallucination

Analogs of drugs like psilocybin and LSD show antidepressant-like activity in mice without causing hallucination, researchers report.

27 Jan 2022

Music therapy can be an attractive option to manage menopause symptoms and depressed mood

As researchers continue to seek effective treatment options for menopause symptoms as alternatives to proven pharmacologic solutions, a number of innovative therapies have been shown to improve symptoms.

27 Jan 2022

Alterations of sphingolipids and their metabolizing enzymes in hospitalized or convalescent COVID-19 patients

An interdisciplinary team of researchers from Europe analyzed the alterations of sphingolipids and their metabolizing enzymes in hospitalized or convalescent COVID-19 patients.

26 Jan 2022

Estrogen-activated neurocircuit in females provide anti-obesity benefits

Seeking to better understand the key role the female hormone estrogen plays in maintaining energy balance and weight control, a group led by researchers at Baylor College of Medicine looked into estrogen interactions with specific brain regions that provide these anti-obesity benefits.

20 Jan 2022

Researchers identify a biomarker in platelets that tracks the extent of depression

Researchers are one step closer to developing a blood test that provides a simple biochemical hallmark for depression and reveals the efficacy of drug therapy in individual patients.

3 Jan 2022

AAN issues new guideline on oral and topical treatments for painful diabetic neuropathy

Diabetic neuropathy refers to nerve damage due to diabetes and it may lead to pain and numbness, most often in the hands and feet. To help neurologists and other doctors determine the best treatment for people with diabetic neuropathy, the American Academy of Neurology (AAN) has issued a guideline on oral and topical treatments for painful diabetic neuropathy.

28 Dec 2021

Doctors advised to prescribe fewer antidepressants and for shorter periods of time

Doctors should prescribe fewer antidepressants and for shorter periods of time, because of the ongoing uncertainties about their effectiveness and the potential severity and durability of the withdrawal symptoms associated with them, suggests a review of the evidence on antidepressant use, published online in the Drug and Therapeutics Bulletin.

21 Dec 2021

Serotonin News and Research

Latest Serotonin News and Research

A psychedelic drug plus psychotherapy could help improve PTSD symptoms

Novel metabolic mechanisms contribute to how ovarian cancer evades immune attack, research finds

Study delineates how drug-induced changes of conscious awareness are rooted in neurotransmitter receptors

Researchers unravel how parent's gene impact the behavior of children

Touch-sensing protein in the gut likely plays a key role in constipation

Pregnant and postpartum women experience depression, anxiety despite treatment with antidepressants

TTUHSC expert wins NIH renewal grant to continue research on neurological disorders

UC joins nationwide trial to evaluate efficacy of repurposed drugs for mild-to-moderate COVID-19

Medications, measurements of physical function could predict fall and fracture risk in older women

Drugs used to increase insulin signaling may be effective therapeutic strategy for autism

UCLA researchers develop a smartwatch that assesses cortisol levels found in sweat

Cerebrovascular impairment persists months after severe acute COVID-19, UK study

Scientists identify genome regions linked to migraine risk

Psychedelic analogs show antidepressant-like activity in mice without causing hallucination

Music therapy can be an attractive option to manage menopause symptoms and depressed mood

Alterations of sphingolipids and their metabolizing enzymes in hospitalized or convalescent COVID-19 patients

Estrogen-activated neurocircuit in females provide anti-obesity benefits

Researchers identify a biomarker in platelets that tracks the extent of depression

AAN issues new guideline on oral and topical treatments for painful diabetic neuropathy

Doctors advised to prescribe fewer antidepressants and for shorter periods of time

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Serotonin News and Research

Latest Serotonin News and Research

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Newsletters you may be interested in